4.7 Article

Subtyping depression in the medically ill by cluster analysis

期刊

JOURNAL OF AFFECTIVE DISORDERS
卷 132, 期 3, 页码 383-388

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2011.03.004

关键词

Major depressive disorder; Diagnostic Criteria for Psychosomatic; Research; Medically ill; Cluster analysis

资金

  1. Compagnia di San Paolo, Torino, Italy
  2. Ely-Lilly
  3. Janssen-Cilag
  4. AstraZeneca
  5. Bristol Meyers Squibb
  6. Lundbeck
  7. Pfeizer
  8. Glaxo-SmithKline

向作者/读者索取更多资源

Background: There is increasing awareness of the need of subtyping major depressive disorder, particularly in the setting of medical disease. The aim of this investigation was to use both DSM-IV comorbidity and the Diagnostic Criteria for Psychosomatic Research (DCPR) for characterizing depression in the medically ill. Methods: 1700 patients were recruited from 8 medical centers in the Italian Health System and 1560 agreed to participate. They all underwent a cross-sectional assessment with DSM-IV and DCPR structured interviews. 198 patients (12.7%) received a diagnosis of major depressive disorder. Data were submitted to cluster analysis. Results: Two clusters were identified: depressed somatizers and irritable/anxious depression. The somatizer cluster included 58.6% of the cases and was characterized by DCPR somatization syndromes (persistent somatization, functional somatic symptoms secondary to a psychiatric disorder, conversion symptoms, and anniversary reactions) and DCPR alexithymia. The anxious/irritable cluster had 41.4% of the total sample and included DCPR irritable mood and type A behavior and DSM-IV anxiety disorders. Limitations: The study has limitations due to its cross-sectional nature. Further, these findings require additional validation in another sample. Conclusions: The findings indicate the need of expanding clinical assessment in the medically ill to include the various manifestations of somatization, irritable mood, type A behavior and alexithymia, as encompassed by the DCPR. Subtyping major depressive disorder may yield improved targets for psychosomatic research and treatment trials. (C) 2011 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据